Investor Presentation Full Year 2017

Investor Presentation Full year 2017 The GLP-1 segment accounts for around 5% of the total diabetes care market in Region Japan & Korea Japan & Korea GLP-1 market Slide 73 VictozaⓇ value market share in Japan & Korea GLP-1 value in bDKK VictozaⓇ exenatide dulaglutide Share of total other diabetes care market GLP-1 value VictozaⓇ market share exenatide dulaglutide other 1.6 3% 100% 1.4 CAGR value¹: 19.6% 80% 1.2 2% 1.0 60% 0.8 40% 49% 41% 0.6 1% 0.4 20% 0.2 0.0 0% 0% Nov 2012 Nov 2017 Nov 2012 6% 4% Nov 2017 1 CAGR for 5-year period Source: IQVIA (formerly IMS) monthly MAT Nov, 2017 value figures (DKK) changing diabetes® Source: IQVIA (formerly IMS) monthly MAT Nov, 2017 value figures (DKK) novo nordisk

View entire presentation